Safety and Efficacy of Low Dose CD19 Targeted Chimeric Antigen Receptor T (CAR-T) Cell Immunotherapy in 47 Cases with Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL)

被引：6
|
作者：
Deng, Biping [1 ]
Chang, Alex Hongsheng [2 ]
Yang, Junfang [3 ]
Pan, Jing [3 ]
Zhang, Xian [3 ]
Lin, Yuehui [3 ]
Wu, Yanan [1 ]
Deng, Zhenling [1 ]
Lu, Peihua [3 ]
Wu, Tong [4 ]
Liu, Zhaoli [1 ]
Zhang, Yu'e [1 ]
Tong, Chunrong [3 ]
机构：
[1] Hebei Yanda Lu Daopei Hosp, Immunotherapy Dept, Langfang, Peoples R China
[2] Tongji Univ, Sch Med, Shanghai, Peoples R China
[3] Hebei Yanda Lu Daopei Hosp, Hematopathol, Langfang, Peoples R China
[4] Hebei Yanda Lu Daopei Hosp, Bone Marrow Transplantat, Langfang, Peoples R China
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.649.649
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
649
引用
收藏
页数：7
相关论文
共 50 条
  • [31] CD19/CD22 Dual-Targeted Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Aggressive B-Cell Lymphoma: a Safety and Efficacy Study
    Hu, Yongxian
    Zhang, Yanlei
    Zhao, Houli
    Wang, Yiyun
    Nagler, Arnon
    Chang, Alex Hong
    Huang, He
    BLOOD, 2020, 136
  • [32] Analysis of Factors Predicting Treatment Response of 254 Patients Who Received CD19-Targeted CAR-T Cell Therapy for Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL)
    Zhang, Xian
    Yang, Junfang
    Shi, Yanze
    Song, Dan
    Li, Jingjing
    Lu, Xin-an
    Wu, Fei
    Li, Jianqiang
    Chen, Dandan
    Li, Xiangqun
    Xu, Zhongwei
    Liu, Shuqiang
    Li, Ziyu
    Ying, Kui
    Wang, Wenya
    Lu, Peihua
    BLOOD, 2019, 134
  • [33] Allogeneic chimeric antigen receptor T cells for children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    Locatelli, Franco
    del Bufalo, Francesca
    Quintarelli, Concetta
    HAEMATOLOGICA, 2024, 109 (06) : 1689 - 1699
  • [34] The Efficacy of Chidamide Maintenance Therapy after CAR-T Therapy for Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia
    Zhang, Xian
    Huang, Lefu
    Zhang, Gailing
    Su, Yunchao
    Hu, Xiaona
    Xia, Shulian
    Li, Jingjing
    Lu, Peihua
    BLOOD, 2022, 140 : 8884 - 8885
  • [35] Anti-CD19/CD22 Dual CAR-T Therapy for Refractory and Relapsed B-Cell Acute Lymphoblastic Leukemia
    Yang, Junfang
    Jiang, Pengfei
    Zhang, Xian
    Zhu, Xiaobin
    Dong, Qi
    He, Jiaping
    Lin, Nanjing
    Wang, Zhenguang
    Cai, Songbai
    Ye, Xun
    Su, Yunchao
    Li, Wenqian
    Li, Jingjing
    Yu, Ziyao
    He, Jiujiang
    Xu, Li
    Song, Dan
    Cao, Wei
    Lu, Peihua
    BLOOD, 2019, 134
  • [36] CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
    Hu, Yongxian
    Zhou, Yali
    Zhang, Mingming
    Ge, Wengang
    Li, Yi
    Yang, Li
    Wei, Guoqing
    Han, Lu
    Wang, Hao
    Yu, Shuhui
    Chen, Yi
    Wang, Yanbin
    He, Xiaohong
    Zhang, Xingwang
    Gao, Ming
    Yang, Jingjing
    Li, Xiuju
    Ren, Jiangtao
    Huang, He
    CLINICAL CANCER RESEARCH, 2021, 27 (10) : 2764 - 2772
  • [37] Efficacy and safety comparison of CAR-T and blinatumomab immunotherapy as bridge-to-transplant strategies in relapsed/refractory B cell acute lymphoblastic leukemia
    Cao, Wenyue
    Li, Ningwen
    Wang, Gaoxiang
    Xu, Hao
    Yang, Yang
    Wang, Jue
    Xu, Jinhuan
    Li, Yun
    Zhang, Yicheng
    Cao, Yang
    Wang, Na
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [38] CASES OF RELAPSED AND REFRACTORY B CELL PRECURSOR-ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY
    Kurita, Daisuke
    Yamanishi, Jun
    Osuna, Mitsumasa
    Ikeda, Junji
    Tsujimoto, Shinichi
    Takeuchi, Masanobu
    Tanoshima, Reo
    Shiba, Norio
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S104 - S104
  • [39] CD19-Targeted CAR-T Cell Therapy for 32 B-Cell Acute Lymphoblastic Leukemia (B-ALL) PatientsWHO Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation (ALLO-HSCT)
    Zhang, Xian
    Yang, Junfang
    Zhang, Jianping
    Li, Jingjing
    Li, Wenqian
    Lu, Peihua
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 171 - 172
  • [40] CD19-targeted chimeric antigen receptor (CAR) T cells in CNS relapsed acute lymphoblastic leukemia (ALL).
    Newman, Haley
    Leahy, Allison Emily Barz
    Li, Yimei
    Liu, Hongyan
    Myers, Regina M.
    DiNofia, Amanda M.
    Dolan, Joseph Gregory
    Callahan, Colleen
    Devine, Kaitlin J.
    Wray, Lisa
    June, Carl H.
    Grupp, Stephan A.
    Rheingold, Susan R.
    Maude, Shannon L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345